Qiagen subsidiary Operon said it has discontinued sales of its pre-fabricated, medium-density OpArrays in North America, due to concerns that they might infringe on Affymetrix s patent portfolio.
They can t be first. But Agilent Technologies, Incyte, and Corning all know they may be able to capture a share of the high-density microarray market by providing products researchers view as better than Affymetrix GeneChips, and each company is trying to figure out the magic formula for doing so.
AT A GLANCE: Received his PhD in molecular biology from UCLA in 1989. Worked with Michael Grunstein to examine the function of histone H4 in S. cerevisiae. Post-doctoral research at CalTech with Paul Sternberg, exploring gene function in C. elegans development.
This is a sample story for bio array news and mcirochips and arrays of all natures. If you want to go further we can go into all kinds of screwwy details about the following: ChipsDipsSpreadsSauces.You name it.
